94
Views
19
CrossRef citations to date
0
Altmetric
Review

The 'non-falciparum' malarias: the roles of epidemiology, parasite biology, clinical syndromes, complications and diagnostic rigour in guiding therapeutic strategies

&
Pages 283-301 | Published online: 18 Jul 2013

References

  • Abdurrahman, M. B., Greenwood, B. M., Narayana, P., Babaoye, F. A. & Edington, G. M. (1981). Immunological aspects of nephrotic syndrome in northern Nigeria. Archives of Diseases in Childhood, 56, 199–202.
  • Abdurrahman, M. B., Aikhionbare, H. A., Babaoye, F. A., Sathiakumar, N. & Narayana, P. T. (1990). Clinicopathological features of childhood nephrotic syndrome in northern Nigeria. Quarterly Journal of Medicine, 75, 563–576.
  • Agarwal, R., Nath, A. & Gupta, D. (2007). Noninvasive ventilation in Plasmodium vivax related ALI/ARDS. Internal Medicine, 46, 2007–2011.
  • Amino, R., Thiberge, S., Martin, B., Celli, S., Shorte, S., Frischknecht, F. & Menard, R. (2006). Quantitative imaging of Plasmodium transmission from mosquito to mammal. Nature Medicine, 12, 220–224.
  • Anochie, I., Eke, F. & Okpere, A. (2006). Childhood nephrotic syndrome: change in pattern and response to steroids. Journal of the National Medical Association, 98, 1977–1981.
  • Baird, J. K. (2004). Resistance to chloroquine by Plasmodium vivax. Antimicrobial Agents and Chemotherapy, 48, 4075–4083.
  • Baird, J. K. & Hoffman, S. L. (2004). Primaquine therapy for malaria. Clinical Infectious Diseases, 39, 1336–1345.
  • Baird, J. K. & Rieckmann, K. (2003). Can primaquine therapy for vivax malaria be improved? Trends in Parasitology, 19, 115–120.
  • Baird, J. K., Pumomo, & Masbar, S. (1990). Plasmodium ovale in Indonesia. Southeast Asian Journal of Tropical Medicine and Public Health, 21, 541-544.
  • Baird, J. K., Krisin, Barcus, M. J., Elyazar, I. R., Bangs, M. J., Maguire, J. D., Fryauff, D. J., Richie, T. L., Sekartuti & Kalalo, W. (2003). Onset of clinical immunity to Plasmodium falciparum among Javanese migrants to Indonesian Papua. Annals of Tropical Medicine and Parasitology, 97, 557–564.
  • Barcus, M. J., Basri, H., Picarima, H., Manyakori, C., Sekartuti, Elyazar, I., Bangs, M. J., Maguire, J. D. & Baird, J. K. (2007). Demographic risk factors for severe and fatal vivax and falciparum malaria among hospital admissions in northeastern Indonesian Papua. American Journal of Tropical Medicine and Hygiene, 77, 984-991.
  • Bamadas, C., Ratsimbasoa, A., Ranaivosoa, H., Ralaizandry, D., Raveloariseheno, D., Rabekotonorina, V., Picot, S. & Menard, D. (2007). Prevalence and chloroquine sensitivity of Plasmodium malariae in Madagascar. American Journal of Tropical Medicine and Hygiene, 77, 1039–1042.
  • Carlini, M. E., White, A. C. & Atmar, R. L. (1999). Vivax malaria complicated by adult respiratory distress syndrome. Clinical Infectious Diseases, 28, 1182–1183.
  • Chadee, D. D., Tilluckdharry, C. C., Maharaj, P. & Sinanan, C. (2000). Reactivation of Plasmodium malariae infection in a Trinidadian man after neurosurgery. New England Journal of Medicine, 342, 1924.
  • Chin, W., Contacos, P. G., Coatney, G. R. & Kimball, H. R. (1965). A naturally-acquired quotidian-type malaria in man transferable to monkeys. Science, 149, 865.
  • Church, L. W., Le, T. P., Bryan, J. P., Gordon, D. M., Edelman, R., Fries, L., Davis, J. R., Herrington, D. A., Clyde, D. F., Shmuklarsky, M. J., Schneider, I., McGovern, T. W., Chulay, J. D., Ballou, W. R. & Hoffman, S. L. (1997). Clinical manifestations of Plasmodium falciparum malaria experimentally induced by mosquito challenge. Journal of Infectious Diseases, 175, 915-920.
  • Coamey, G. R., Collins, W. E., Warren, M. & Contacos, P. G. (1971). Plasmodium ovale. In The Primate Malarias, p. 171. Washington, DC: United States Government Printing Office.
  • Collins, W. E. & Jeffery, G. M. (2002). Extended clearance time after treatment of infections with Plasmodium malariae may not be indicative of resistance to chloroquine. American Journal of Tropical Medicine and Hygiene, 67, 406–410.
  • Collins, W. E., Contacos, P. G. & Chin, W. (1973). Experimental infection in man with Plasmodium malariae. American Journal of Tropical Medicine and Hygiene, 22, 685–692.
  • Cox-Singh, J., Davis, T. M., Lee, K. S., Shamsul, S. S., Matusop, A., Ratnam, S., Rahman, H. A., Conway, D. J. & Singh. B. (2008). Plasmodium knowlesi malaria in humans is widely distributed and potentially life threatening. Clinical Infectious Diseases, 46, 165–171.
  • Curlin, M. E., Barat, L. M., Walsh, D. K. & Granger, D. L. (1999). Noncardiogenic pulmonary edema during vivax malaria. Clinical Infectious Diseases, 28, 1166–1167.
  • Davis, T. M., Singh, B. & Sheridan, G. (2001). Parasitic procrastination: late-presenting ovale malaria and schistosomiasis. Medical Journal of Australia, 175,146–148.
  • Dixon, K. E., Pitaktong, U., Bamnetpandh, S., Teopipithapom, S. & Na-Nakorn, A. (1983). Treatment of an acute case of Plasmodium malariae malaria with mefloquine. American Journal of Tropical Medicine and Hygiene, 32,631–632.
  • Ehrich, J. H. & Eke, F. U. (2007). Malaria-induced renal damage: facts and myths. Pediatric Nephrology, 22,626–637.
  • Facer, C. A. & Rouse, D. (1991). Spontaneous splenic rupture due to Plasmodium ovale malaria. Lancet, 338, 896.
  • George, A. O. (2004). Chloroquine-induced pruritis - questionnaire based epidemiological study. African Journal of Health Sciences, 11, 87–92.
  • Gilles, H. M. & Hendrickse, R. G. (1960). Possible aetiological role of Plasmodium malariae in `nephrotic syndrome' in Nigerian children. Lancet, i, 806–807.
  • Gockel, H. R., Heidmann, J., Lorenz, D. & Gockel, I. (2006). Spontaneous splenic rupture, in tertian malaria. Infection, 34,43–45.
  • Goller, J. L., Jolley, D., Ringwald, P. & Biggs, B. (2007). Regional differences in the response of Plasmodium vivax malaria to primaquine as anti-relapse therapy. American Journal of Tropical Medicine and Hygiene, 76, 203–207.
  • Guerra, C. A., Snow, R. W. & Hay, S. I. (2006). Mapping the global extent of malaria in 2005. Trends in Parasitology, 22,353–358.
  • Gupta, O. P., Bajaj, S. & Gupta, S. C. (1989). A study of tropical splenomegaly syndrome and chloroquine prophylaxis. Journal of the Association of Physicians of India, 37,570–575.
  • Habib, A. G. & Singh, K. S. (2004). Respiratory distress in nonimmune adults with imported malaria. Infection, 32,356–359.
  • Hay, S. I., Guerra, C. A., Tatum, A. J., Noor, A. M. & Snow, R. W. (2004). The global distribution and population at risk of malaria: past, present and future. Lancet Infectious Diseases, 4,327–336.
  • Hill, D. R., Baird, J. K., Parise, M. E., Lewis, L. S., Ryan, E. T. & Magill, A. J. (2006). Primaquine: report from CDC expert meeting on malaria chemo-prophylaxis. I. American Journal of Tropical Medicine and Hygiene, 75,402–415.
  • Hoffman, S. L., Piessens, W. F., Ratiwayanto, S., Hussein, P. R., Kurniawan, L., Piessens, P. W., Campbell, J. R. & Marwoto, H. A. (1984). Reduction of suppressor T lymphocytes in the tropical splenomegaly syndrome. New England Journal of Medicine, 310, 337–341.
  • Islam, N. & Qamruddin, K. (1995). Unusual compli-cations in benign tertian malaria. Tropical and Geographical Medicine, 47,141–143.
  • Jimenez, B. C. & Leipez-Velez, R. (2008). Spontaneous splenic rupture due to Plasmodium vivax in a traveler: case report and review. Reply. Journal of Travel Medicine, 15,140–142.
  • Jimenez, B. C., Navarro, M., Huerga, H. & Lopez-Velez, R. (2007). Spontaneous splenic rupture due to Plasmodium vivax in a traveler: case report and review. Journal of Travel Medicine, 14, 188–191.
  • Jongwutiwes, S., Putapomtip, C., Iwasak, T., Sata, T. & Kanbara, H. (2004). Naturally acquired Plasmodium knowlesi malaria in human, Thailand. Emerging Infectious Diseases, 10, 2211–2213.
  • Kennedy Jr, T. J., Zubrod. C. G., Gibelow, F. S., Berliner, R. W. & Shannon, J. A. (1946). A mechanism of drug ‘potentiation’: pamaquin meta-bolism is influenced by quinacrine. Federation Proceedings, 5,185.
  • Kochar, D. K., Saxena, V., Singh, N., Kochar, S. K., Kumar, S. V. & Das, A. (2005). Plasmodium vivax malaria. Emerging Infectious Diseases, 11, 132–134.
  • Koh, K. H., Chew, P. H. & Kiyu, A. (2004). A retrospective study of malaria infections in an intensive care unit of a general hospital in Malaysia. Singapore Medical Journal, 45,28–36.
  • Kotwal, R. S., Wenzel, R. B., Sterling, R. A., Porter, W. D., Jordan, N. N. & Petruccelli, B. P. (2005). An outbreak of malaria among US Army Rangers returning from Afghanistan. Journal of the American Medical Association, 293,212–216.
  • Krudsood, S., Tangpukdee, N., Muangnoicharoen, S., Thanachartwet, V., Luplertlop, N., Srivilairit, S., Wilairatana, P., Kano, S., Ringwald, P. & Looareesuwan, S. (2007). Clinical efficacy of chlor-oquine versus artemether-lumefantrine for Plasmodium vivax treatment in Thailand. Korean Journal of Parasitology, 45,111–114.
  • Kumar, S., Melzer, M., Dodds, P., Watson, J. & Ord, R. (2007). P. vivax malaria complicated by shock and ARDS. Scandanavian Journal of Infectious Diseases, 39,255–256.
  • Lacy, M. D., Maguire, J. D., Barcus, M. J., Ling, J., Bangs, M. J., Gramzinski, R., Basri, H., Sismadi, P., Miller, G. B., Chulay, J. D., Fryauff, D. J., Hoffman, S. L. & Baird, J. K. (2002). Atovaquone/proguanil therapy for Plasmodium falciparum and P. vivax malaria in Indonesians who lack clinical immunity. Clinical Infectious Diseases, 35,92–95.
  • Lawn, S. D., Krishna, S., Jarvis, J. N., Joet, T. & Macallan, D. C. (2003). Case reports: pernicious complications of benign tertian malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene, 97, 551–553.
  • Lomar, A. V., Vidal, J. E., Lomar, F. P., Barbas, C. V., de Matos, G. J. & Boulos, M. (2005). Acute respiratory distress syndrome due to vivax malaria: case report and literature review. Brazilian Journal of Infectious Diseases, 9, 425–430.
  • Lubitz, J. M. (1949). Pathology of the ruptured spleen in acute vivax malaria. Blood, 4, 1168–1176.
  • Luchavez, J., Espino, F., Curameng, P., Espina, R., Bell, D., Chiodini, P., Nolder, D., Sutherland, C., Lee, K. S. & Singh, B. (2008). Human infections with Plasmodium knowlesi, the Philippines. Emerging Infectious Diseases, 14, 811–813.
  • Maguire, J. D., Lacy, M. D., Sururi, Sismadi, P., Krisin, Wiady, I., Laksana, B., Bangs, M. J., Masbar, S., Susanti, I., Basuki, W., Barcus, M. J., Marwoto, H., Edstein, M. D., Tjokrosonto, S. & Baird, J. K. (2002a). Chloroquine or sulfadoxine-pyrimethamine for the treatment of uncomplicated, Plasmodium falciparum malaria during an epidemic in Central Java, Indonesia. Annals of Tropical Medicine and Parasitology, 96, 655–668.
  • Maguire, J. D., Sumawinata, I. W., Masbar, S., Laksana, B., Prodjodipuro, P., Susanti, I., Sismadi, P., Bangs, M. J. & Baird, J. K. (2002b). Chloroquine-resistant Plasmodium malariae in south Sumatra, Indonesia. Lancet, 360, 58–60.
  • Maguire, J. D., Bangs, M. J., Brennan, L., Rieckmann, K. & Taleo, G. (2006a). Cross-sectional characterization of malaria in Sanma and Shefa provinces, Republic of Vanuatu: malaria control implications. Papua New Guinea Medical Journal, 49, 22–31.
  • Maguire, J. D., Krisin, Marwoto, H., Richie, T. L., Fryauff, D. J. & Baird, J. K. (2006b). Mefloquine is highly efficacious against chloroquine-resistant Plasmodium vivax malaria and P. falciparum malaria in Papua, Indonesia. Clinical Infectious Diseases, 42, 1067-1072.
  • Maguire, J. D., Fenton, M. E., Susanti, A. I. & Walker, J. B. (2007). Plasmodium vivax associated acute respiratory distress syndrome after extended travel in Afghanistan. Travel Medicine and Infectious Disease, 5,301–305.
  • Mavrikakis, I., Sfikakis, P., Mavrikakis, E., Rougas, K., Nikolaou, A., Kostopoulos, C. & Mavrikakis, M. (2003). The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine. Ophthalmology, 110, 1321–1326.
  • Michaud, E., Ninet, J., Coppere, B., Bachet, P., Chaumentin, G., Rague, S. & Pasquier, J. (1992). Nephrotic syndrome caused by Plasmodium malariae infection. A case with favourable outcome. Presse Médicale, 21, 1386.
  • Miyashita, N., Karino, T., Nagatomo, Y., Yoshida, K., Nakajima, M., Okimoto, N., Niki, Y. & Soejima, R. (1995). A case of Plasmodium ovale malaria with thrombocytopenia and an abnormality grade in FDP concentration despite the use of chloroquine as a malaria prophylaxis. Kansenshogaku Zasshi, 69, 450–454.
  • Moraes, M. F., Soares, M., Arroz, M. J., do Rosário, V. E., da Graça, J. P. & Abecasis, P. (2003). New concepts in hyperactive malarial splenomegaly. Acta Médica Portuguesa, 16, 41-46.
  • Morovic, M., Poljak, I., Miletic, B., Troselj-Vukic, B., Seili-Bekafigo, I. & Milotic, I. (2003). Late sympto-matic Plasmodium malariae relapse in the territory of the former Yugoslavia. Journal of Travel Medicine, 10, 301–302.
  • Mothe, B., Lopez-Contreras, J., Torres, O. H., Munoz, C., Domingo, P. & Gurgui, M. (2008). A case of hyper-reactive malarial splenomegaly. The role of rapid antigen-detecting and PCR-based tests. Infection, 36, 167–169.
  • Moudden, M. K., Boukhira, A., Zyani, M., Boughalem, M. & Hda, A. (2006). Severe imported malaria: the experience of the Avicenna military hospital in Marrakech. Santé, 16, 259–262.
  • Maller-Stöver, I., Verweij, J. J., Hoppenheit, B., Göbels, K., Haussinger, D. & Richter, J. (2008). Plasmodium malariae infection in spite of previous anti-malarial medication. Parasitology Research, 102, 547–550.
  • Munteis, E., Mellibovsky, L., Marquez, M. A., Minguez, S., Vázquez, E. & Diez A. (1997). Pulmonary involvement in a case of Plasmodium vivax malaria. Chest, 111, 834–835.
  • Nathwani, D., Currie, P. F., Smith, C. C. & Khaund, R. (1991). Recurrent Plasmodium ovale infection from Papua New Guinea - chloroquine resistance or inadequate primaquine therapy? Journal of Infection, 23, 343–344.
  • Neri, S., Pulvirenti, D., Patamia, I., Zoccolo, A. & Castellino, P. (2008). Acute renal failure in Plasmodium malariae infection. Netherlands Journal of Medicine, 66, 166–168.
  • Ng, O. T., Ooi, E. E., Lee, C. C., Lee, P. J., Ng, L. C., Pei, S. W., Tu, T. M., Loh, J. P. & Leo, Y. S. (2008). Naturally acquired human Plasmodium knowlesi infec-tion, Singapore. Emerging Infectious Diseases, 14, 814–816.
  • Nicolas, J. F., Mauduit, G., Haond, J., Chouvet, B. & Thivolet, J. (1988). Severe psoriasis induced by chloroquine (nivaquine). Annales de Dermatologie et de Vénéréologie, 115, 289–293.
  • Paparello, S. & Hoffman, S. (1992a). Hyperreactive malarial splenomegaly: part I. Post Graduate Doctor Middle East, 15, 336–340.
  • Paparello, S. & Hoffman, S. (1992b). Hyperreactive malarial splenomegaly: part II. Post Graduate Doctor Middle East, 15, 374–378.
  • Perren, A., Beretta, F. & Schubarth, P. (1998). ARDS in Plasmodium vivax malaria. Schweizerische Medizinische Wochenschrift, 128, 1020–1023.
  • Phillips, R. E. & Solomon, T. (1990). Cerebral malaria in children. Lancet, 336, 1355–1360.
  • Poespoprodjo, J. R., Fobia, W., Kenangalem, E., Lampah, D. A., Hasanuddin, A., Warikar, N., Sugiarto, P., Tjitra, E., Anstey, N. M. & Price, R. N. (2009). Vivax malaria: a major cause of morbidity in early infancy. Clinical Infectious Diseases, 48, 1704–1712 .
  • Price, L., Planche, T., Rayner, C. & Krishna, S. (2007). Acute respiratory distress syndrome in Plasmodium vivax malaria: case report and review of the literature. Transactions of the Royal Society of Tropical Medicine and Hygiene, 101, 655–659.
  • Pukrittayakarnee, S., Chantra, A., Vanijanonta, S. & White, N. J. (1998). Pulmonary oedema in vivax malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene, 92, 421–422.
  • Pukrittayakamee, S., Chantra, A., Simpson, J. A., Vanijanonta, S., Clemens, R., Looareesuwan, S. & White, N. J. (2000). Therapeutic responses to different antimalarial drugs in vivax malaria. Antimicrobial Agents and Chemotherapy, 44,1680–1685.
  • Ratcliff, A., Siswantoro, H., Kenangalem, E., Maristela, R, Wuwung, R. M., Laihad, F., Ebsworth, E. P., Anstey, N. M., Tjitra, E. & Price, R. N. (2007). Two fixed-dose artemisinin combina-tions for drug-resistant falciparum and vivax malaria in Papua, Indonesia; an open-label randomized comparison. Lancet, 369, 757–765.
  • Rifakis, P. M., Hernandez, O., Fernandez, C. T., Rodriguez-Morales, A. J., Von, A. & Franco-Paredes, C. (2008). Atypical Plasmodium vivax malaria in a traveler: bilateral hydronephrosis, severe thrombocy-topenia, and hypotension. Journal of Travel Medicine, 15, 119-121.
  • Ringwald, P., Bickii, J., Same-Ekobo, A. & Basco, L. K. (1997). Pyronaridine for treatment of Plasmodium ovale and Plasmodium malariae infections. Antimicrobial Agents and Chemotherapy, 41, 2317–2319.
  • Rombo, L., Edwards, G., Ward, S. A., Eriksson, G., Lindquist, L., Lindberg, A., Runehagen, A., Björkman, A. & Hylander, N. O. (1987). Seven patients with relapses of Plasmodium vivax or P. ovale despite primaquine treatment. Tropical Medicine and Parasitology, 38, 49–50.
  • Saleri, N., Gulletta, M., Matteelli, A., Caligaris, S., Tomasoni, L. R., Antonini, B., Perandin, F. & Castelli, F. (2006). Acute respiratory distress syn-drome in Plasmodium vivax malaria in traveler returning from Venezuela. Journal of Travel Medicine, 13, 112–113.
  • Schwartz, E., Parise, M., Kozarsky, P. & Cetron, M. (2003). Delayed onset of malaria - implications for chemoprophylaxis in travelers. New England Journal of Medicine, 349, 1510–1516.
  • Shekalaghe, S. A., Braak, R., Daou. M., Kavishe, R., van den Bijllaardt, W., van den Bosch, S., Koenderink, J. B., Luty, A. J., Whitty, C. J., Drakeley, C., Sauerwein, R. W. & Bousema, T. (2010). In Tanzania, hemolysis after a single dose of primaquine coadministered with an arte-misinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals. Antimicrobial Agents and Chemotherapy, 54, 1762–1768.
  • Siala, E., Khalfaoui, M., Bouratbine, A., Hamdi, S., Hili, K. & Aoun, K. (2005). Relapse of Plasmodium malariae malaria 20 years after living in an endemic area. Presse Médicale, 34, 371–372.
  • Silachamroon, U., Krudsood, S., Treeprasertsuk, S., Wilairatana, P., Chalearmrult, K., Mint, H. Y., Maneekan, P., White, N. J., Gourdeuk, V. R., Brittenham, G. M. & Looareesuwan, S. (2003). Clinical trial of oral artesunate with or without high-dose primaquine for the treatment of vivax malaria in Thailand. American Journal of Tropical Medicine and Hygiene, 69, 14–18.
  • Singh, B., Kim Sung, L., Matusop, A., Radhakrishnan, A., Shamsul, S. S., Cox-Singh, J., Thomas, A. & Conway, D. J. (2004). A large focus of naturally acquired Plasmodium knowlesi infections in human beings. Lancet, 363, 1017–1024.
  • Singh, P. P. & Dutta, G. P. (1981). Antimalarial activity of mefloquine and chloroquine against blood induced Plasmodium knowlesi infection in rhesus monkeys. Indian Journal of Medical Research, 73, 23–28.
  • Svenson, J. E., MacLean, J. D., Gyorkos, T. W. & Keystone, J. (1995). Imported malaria. Clinical presentation and examination of symptomatic trave-lers. Archives of Internal Medicine, 155, 861–868.
  • Tan-ariya, P. & Pasuralertsakul, S. (1994). First report if in vitro susceptibility of Plasmodium malariae Thai isolates to chloroquine. Southeast Asian Journal of Tropical Medicine and Public Health, 25,784–787.
  • Tanios, M. A., Kogelman, L., McGovern, B. & Hassoun, P. M. (2001). Acute respiratory distress syndrome complicating vivax malaria. Critical Care Medicine, 29, 665–667.
  • Thwing, J., Skarbinski, J., Newman, R. D., Barber, A. M., Mali, S., Roberts, J. M., Slutsker, L. & Arguin, P. M. (2007). Malaria surveillance: United States, 2005. Morbidity and Mortality Weekly Report Surveillance Summaries, 56, 23–40.
  • Tjitra, E., Anstey, N. M., Sugiarto, P., Warikar, N., Kenangalem, E., Karyana, M., Lampah, D. A. & Price, R. N. (2008). Multidrug resistant Plasmodium vivax associated with severe and fatal malaria: A prospective study in Papua, Indonesia. PLoS Medicine, 5, e128.
  • Torres, J. R., Perez, H., Postigo, M. M., Silva, J. R. (1997). Acute non-cardiogenic lung injury in benign tertian malaria. Lancet, 350, 31–32.
  • Vinetz, J. M., Li, J., McCutchan, T. F. & Kaslow, D. C. (1998). Plasmodium malariae infection in an asy-mptomatic 74-year-old Greek woman with spleno-megaly. New England Journal of Medicine, 338, 367–371.
  • Vriend, W. H., Hoffman, S. L., Silaban, T. & Zaini, M. (1988). Splenectomy in massive tropical splenome-galy: two- to six-year follow-up in 14 patients. Tropical and Geographical Medicine, 40, 298–303.
  • Wilson, M. E., Weld, L. H., Boggild, A., Keystone, J. S., Kain, K. C., von Sonnenburg, F. & Schwartz, E. (2007). Fever in returned travelers: results from the GeoSentinel Surveillance Network. Clinical Infectious Diseases, 44, 1560–1568.
  • World Health Organization. (1997). Management of Uncomplicated Malaria and Use of Antimalarial Drugs for the Protection of Travellers, Report of an Informal Consultation, Geneva, 18-21 September 1995. Document WHO/MAL/96. 1075. Geneva: WHO.
  • Yamauchi, L. M., Coppi, A., Snounou, G. & Sinnis, P. (2007). Plasmodium sporozoites trickle out of the injection site. Cellular Microbiology, 9, 1215-1222. Zhu, H. M., Li, J. & Zheng, H. (2006). Human natural infection of Plasmodium knowlesi. Zhongguo ji Sheng Chong Xue Yu ji Sheng Chong Bing Za Zhi, 24, 70–71.
  • Zingman, B. S. & Viner, B. L. (1993). Splenic complications in malaria: case report and review. Clinical Infectious Diseases, 16, 223–232.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.